GRITSTONE ONCOLOGY INC's ticker is GRTS and the CUSIP is 39868T105. A total of 82 filers reported holding GRITSTONE ONCOLOGY INC in Q2 2020. The put-call ratio across all filers is - and the average weighting 0.1%.
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Versant Venture Management, LLC | 3,561,150 | $9,152,000 | 15.60% |
Frazier Life Sciences Management, L.P. | 5,237,348 | $13,460,000 | 1.04% |
Redmile Group, LLC | 6,952,760 | $17,869,000 | 0.69% |
Palo Alto Investors LP | 2,330,504 | $5,989,000 | 0.47% |
ACT CAPITAL MANAGEMENT, LLC | 47,500 | $122,000 | 0.17% |
SkyOak Wealth, LLC | 132,851 | $341,000 | 0.12% |
Artal Group S.A. | 750,000 | $1,928,000 | 0.08% |
CORNERCAP INVESTMENT COUNSEL INC | 77,046 | $198,000 | 0.04% |
CAXTON ASSOCIATES LP | 95,190 | $245,000 | 0.03% |
XTX Topco Ltd | 50,517 | $130,000 | 0.03% |